Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Orthofix MedicalOFIX 57 3-Year FCF Growth Rate is 73.60% as of Jun. 2026, which is 1158% above its 10-year median of 5.85. GuruFocus rates OFIX with a GF Score™ of 57/100 and a GF Value™ of $13.93 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 582 Medical Devices & Instruments companies, Orthofix Medical ranks better than 92.44% on this metric.
During the past 12 months, Orthofix Medical's average Free Cash Flow per Share Growth Rate was -3663.20% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 73.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Orthofix Medical was 244.10% per year. The lowest was -61.00% per year. And the median was 5.85% per year.
Orthofix Medical (NAS:OFIX) 3-Year FCF Growth Rate Explanation
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
Orthofix Medical 3-Year FCF Growth Rate Related Terms
OFIX vs VMD, VREX, KIDS: 3-Year FCF Growth Rate Comparison
For the Medical Devices subindustry, Orthofix Medical's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orthofix Medical 3-Year FCF Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where Orthofix Medical's 3-Year FCF Growth Rate falls into.
Orthofix Medical 3-Year FCF Growth Rate Calculation
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
What does a 3-Year FCF Growth Rate of 73.60% mean?
Orthofix Medical (OFIX) has a 3-Year FCF Growth Rate of 73.60% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Orthofix Medical and its competitors. This is 1158% above median its historical median of 5.85. According to the industry distribution chart, Orthofix Medical ranks #44 out of 582 companies in the Medical Devices & Instruments industry, placing it in the top 7.6%.
Is Orthofix Medical's 3-Year FCF Growth Rate too high?
Orthofix Medical's current 3-Year FCF Growth Rate of 73.60% is 1158% above median its 10-year median of 5.85. The Medical Devices & Instruments industry median 3-Year FCF Growth Rate is 17.75. Orthofix Medical's value of 73.60% is 314.6% above this industry median. Based on the distribution chart, Orthofix Medical ranks #44 out of 582 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Orthofix Medical has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Orthofix Medical's 3-Year FCF Growth Rate compare to VMD and VREX?
According to the Medical Devices & Instruments industry distribution chart, Orthofix Medical ranks #44 out of 582 companies for 3-Year FCF Growth Rate. This places Orthofix Medical in the top 8% of its industry — outperforming the majority of peers. The industry median 3-Year FCF Growth Rate is 17.75. Orthofix Medical's value of 73.60% is 314.6% above this benchmark. While the company's 10-year median is 5.85 vs. the industry median of 17.75, Orthofix Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Medical Devices & Instruments company?
The median 3-Year FCF Growth Rate among Medical Devices & Instruments companies is 17.75, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orthofix Medical's current 3-Year FCF Growth Rate of 73.60% is 314.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Orthofix Medical and its competitors. For the Medical Devices & Instruments industry, the median 3-Year FCF Growth Rate is 17.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orthofix Medical's current 3-Year FCF Growth Rate is 73.60%, which is 1158% above median its own 10-year median of 5.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orthofix Medical stock overvalued right now?
Based on GuruFocus' analysis, Orthofix Medical (OFIX) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.93, compared to a current price of $10.01 — trading 28.1% below its estimated fair value. The current 3-Year FCF Growth Rate is 73.60%, which is 1158% above median its 10-year median of 5.85 and 314.6% above the Medical Devices & Instruments industry median of 17.75. Orthofix Medical's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For Orthofix Medical (OFIX), the current 3-Year FCF Growth Rate is 73.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orthofix Medical (OFIX) Overvalued in 2026?
Based on GuruFocus' analysis, Orthofix Medical stock appears to be undervalued.
The current stock price of $10.01 is trading 28.1% below its estimated GF Value™ of $13.93.
GuruFocus considers Orthofix Medical to be Modestly Undervalued.
Key valuation signals for OFIX:
3-Year FCF Growth Rate: 73.60% (1158% above median its 10-year median of 5.85)
GF Value™: $13.93 vs. price of $10.01 (28.1% below fair value)
Industry Position: 314.6% above the Medical Devices & Instruments median (#44 of 582)
No single metric tells the full story. See the OFIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
57GF Score
Get the complete analysis for OFIX
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OFIX has been successfully added to your 
